|

EBX-102 Clinical Trials

1 actively recruiting trial

Also known as: IMT capsules

Pipeline

Phase 2: 1

Top Sponsors

  • Imperial College London1

Indications

  • Chronic Myeloid Leukemia1
  • Acute Lymphoblastic Leukaemia1
  • Chronic Myelomonocytic Leukemia1
  • Acute Leukemia of Ambiguous Lineage1
  • Myelodysplastic Syndrome1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.